Hewatele
Go backHewatele Combats Maternal and Child Mortality with Cutting-edge Cryogenic Medical Liquid Oxygen Plant at Tatu City, Kenya
Hewatele has invested USD 20 million to build a state-of-the-art Cryogenic Medical Liquid Oxygen Air Separation Unit in Tatu City Special Economic Zone, boosting the supply of affordable medical oxygen and supporting maternal and child healthcare in East Africa. Hewatele brought together funding from American, Finnish and Canadian governments through the U.S. International Development Finance Corporation, Finnfund, Soros Economic Development Fund, UBS Optimus Foundation, and Grand Challenges Canada. The plant is set to begin operations early 2025.
“This medical oxygen plant represents a significant leap in ensuring sustainable and affordable access to medicinal oxygen. The increased production capacity here at Tatu City will improve oxygen affordability, particularly for maternal and child healthcare, and enhance primary healthcare support.” – Dr. Bernard Olayo, Founder of Hewatele.